ACE and acute kidney injury: In the cohort that developed postinterventional AKI, patients were younger (p = 0.019), significantly fewer patients received angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy (p = 0.004), and baseline renal function was significantly lower.